Dr. Stephen Richey
Claim this profileTexas Oncology - Fort Worth
Studies Non-Small Cell Lung Cancer
Studies Colorectal Cancer
8 reported clinical trials
17 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage IV
KRAS positive
2Colorectal Cancer
Stage IV
Stage III
KRAS positive
Affiliated Hospitals
Clinical Trials Stephen Richey is currently running
Aplitibart
for Metastatic Colorectal Cancer
This trial is testing a new drug called aplitibart with standard chemotherapy and another drug in patients with metastatic colorectal cancer that has come back or spread. The treatment works by killing cancer cells and cutting off their nutrient supply.
Recruiting1 award Phase 16 criteria
Avutometinib + Sotorasib
for Lung Cancer
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with sotorasib with or without defactinib in patients with KRAS G12C Non-Small Cell Lung Cancer (NSCLC) in patients who have been exposed to prior G12C inhibitor and those who have not been exposed to prior G12C inhibitor.
Recruiting1 award Phase 1 & 2
More about Stephen Richey
Clinical Trial Related5 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Stephen Richey has experience with
- Docetaxel
- SM08502
- Abiraterone
- PTC299
- IGM-8444
- FOLFIRI
Breakdown of trials Stephen Richey has run
Non-Small Cell Lung Cancer
Colorectal Cancer
Prostate Cancer
Acute Myeloid Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephen Richey specialize in?
Stephen Richey focuses on Non-Small Cell Lung Cancer and Colorectal Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Stephen Richey currently recruiting for clinical trials?
Yes, Stephen Richey is currently recruiting for 4 clinical trials in Fort Worth Texas. If you're interested in participating, you should apply.
Are there any treatments that Stephen Richey has studied deeply?
Yes, Stephen Richey has studied treatments such as Docetaxel, SM08502, Abiraterone.
What is the best way to schedule an appointment with Stephen Richey?
Apply for one of the trials that Stephen Richey is conducting.
What is the office address of Stephen Richey?
The office of Stephen Richey is located at: Texas Oncology - Fort Worth, Fort Worth, Texas 76104 United States. This is the address for their practice at the Texas Oncology - Fort Worth.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.